Member Profile - mccibd.org to Beximco Group, the largest private sector industrial conglomerate in...
1
20 CHAMBER NEWS February 2013 02 The company was incorporated in 1976 and commenced operations in 1980 with the manufacturing and marketing of products of Bayer AG, Germany and Upjohn Inc., USA under licensing arrangements. In 1983, the company started manufacturing its own formulations. Today Beximco Pharma is the largest exporter of pharmaceuticals in the country and the only company to win National Export Trophy (Gold) a record 4 times. The company is the largest producer of Metered Dose Inhalers (MDIs) in the country, and the first to produce eco-friendly CFC free inhalers. BPL is also the first company to produce anti-retroviral drugs (ARVs) locally. With decades of contract manufacturing experience with global MNCs, skilled manpower and proven formulation capabilities, the company has been building a visible and growing presence across the continents offering high quality and affordable medicines. Ensuring access to quality medicines is the powerful aspiration that motivates eximco Pharmaceuticals Ltd. (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. The company belongs to Beximco Group, the largest private sector industrial conglomerate in the country. Beximco Pharma’s state-of – the-art manufacturing facilities are certified by global regulatory authorities of Australia, European Union, Gulf nations, and Brazil, among others. The company is consistently building upon its portfolio of products, currently producing more than 500 products in different dosage forms encompassing broader therapeutic categories. 2700 employees of the organization. Beximco Pharma’s manufacturing site extends over an area of 23 acres which houses manufacturing facilities for producing various drugs in different delivery systems such as capsules, tablets, intravenous fluids, metered dose inhalers, sterile ophthalmic drops, prefilled syringes, dry powder inhalers, injectable and nebulizer solutions. The bulk drug unit for producing paracetamol is also located within this site. The company’s penicillin API and formulation units are situated at Kaliakoir, a few kilometers from the main site. Beximco Pharma has the highest number of international accreditations among all the pharmaceutical companies in the country. As a public limited company, its shares are actively traded in Dhaka Stock Exchange and Chittagong Stock Exchange, and Beximco Pharma has the unique distinction of being the only company in the country to get listed on AIM of London Stock Exchange. Member Profile Beximco Pharmaceuticals Ltd. B
Transcript of Member Profile - mccibd.org to Beximco Group, the largest private sector industrial conglomerate in...
20
CHAMBER NEWS February 201302
The company was incorporated in 1976 and commenced operations in 1980 with the manufacturing and marketing of products of Bayer AG, Germany and Upjohn Inc., USA under licensing arrangements. In 1983, the company started manufacturing its own formulations. Today Beximco Pharma is the largest exporter of pharmaceuticals in the country and the only company to win National Export Trophy (Gold) a record 4 times. The company is the largest producer of Metered Dose Inhalers (MDIs) in the country, and the first to produce eco-friendly CFC free inhalers. BPL is also the first company to produce anti-retroviral drugs (ARVs) locally.
With decades of contract manufacturing experience with global MNCs, skilled manpower and proven formulation capabilities, the company has been building a visible and growing presence across the continents offering high quality and affordable medicines. Ensuring access to quality medicines is the powerful aspiration that motivates
eximco Pharmaceuticals Ltd. (BPL) is a leading
manufacturer of pharmaceutical formulations
and Active Pharmaceutical Ingredients (APIs) in
Bangladesh. The company belongs to Beximco Group, the largest private sector industrial
conglomerate in the country. Beximco Pharma’s state-of –
the-art manufacturing facilities are certified by global regulatory
authorities of Australia, European Union, Gulf nations, and Brazil, among others. The
company is consistently building upon its portfolio of products, currently producing more than
500 products in different dosage forms encompassing broader
therapeutic categories.
2700 employees of the organization. Beximco Pharma’s manufacturing site extends over an area of 23 acres which houses manufacturing facilities for producing various drugs in different delivery systems such as capsules, tablets, intravenous fluids, metered dose inhalers, sterile ophthalmic drops, prefilled syringes, dry powder inhalers, injectable and nebulizer solutions. The bulk drug unit for producing paracetamol is also located within this site. The company’s penicillin API and formulation units are situated at Kaliakoir, a few kilometers from the main site.
Beximco Pharma has the highest number of international accreditations among all the pharmaceutical companies in the country. As a public limited company, its shares are actively traded in Dhaka Stock Exchange and Chittagong Stock Exchange, and Beximco Pharma has the unique distinction of being the only company in the country to get listed on AIM of London Stock Exchange.
Member Profile
Beximco Pharmaceuticals Ltd.
B
